HTFLHeartflow, Inc.vs its industry peers
A metric-by-metric comparison of Heartflow, Inc. against Surgical & Medical Instruments & Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HTFLEsta | $4.3B#8 | 16.6x#2 | 15.4x#14 | 24.5x#15 | 39.9%#1 | -21.1%#10 | -36.4%#14 | -41.8%#15 | — | — | 56.7%#5 | — |
| GMED | $10.0B#1 | 19.0x#3 | 2.1x#4 | 3.4x#7 | 16.7%#7 | 422.3%#1 | 16.3%#3 | 11.3%#5 | — | — | 32.0%#7 | — |
| PODD | $9.8B#2 | 26.6x#4 | 6.9x#12 | 3.6x#9 | 30.7%#3 | -40.9%#13 | 17.5%#2 | 17.4%#2 | 17.7%#1 | 7#1 | -56.0%#15 | — |
| GKOS | $9.5B#3 | — | 14.0x#13 | 18.8x#14 | 32.3%#2 | -28.2%#11 | -39.3%#15 | -27.5%#12 | -34.9%#9 | 3#10 | 96.8%#3 | — |
| MMED | $6.2B#4 | — | 1.7x#1 | 2.0x#2 | 14.3%#9 | -56.3%#15 | -6.1%#11 | -9.2%#10 | — | — | — | — |
| TFX | $5.3B#5 | — | 1.8x#3 | 2.7x#4 | 17.2%#6 | -1390.8%#16 | 5.9%#7 | -31.2%#13 | 2.2%#6 | 4#9 | 0.9%#11 | 1.1%#1 |
| MMSI | $5.1B#6 | 35.2x#7 | 3.0x#6 | 3.4x#6 | 11.8%#12 | 6.8%#9 | 12.2%#5 | 7.6%#6 | 7.1%#4 | 7#1 | 3.6%#10 | — |
| HAE | $4.9B#7 | 52.0x#8 | 5.9x#11 | 3.7x#10 | -2.0%#14 | -42.0%#14 | 11.7%#6 | 0.0%#8 | 6.7%#5 | 7#1 | 115.7%#2 | — |
| ICUI | $3.8B#9 | 128.5x#9 | 1.8x#2 | 1.7x#1 | -6.3%#15 | 100.6%#3 | 1.9%#9 | 0.0%#7 | 0.3%#7 | 6#7 | 18.9%#9 | — |
| IRTC | $3.7B#10 | — | 19.8x#15 | 4.9x#11 | 26.2%#4 | 60.2%#5 | -7.7%#12 | -24.2%#11 | — | 6#7 | -35.1%#14 | — |
| PLSE | $3.6B#11 | — | 36.3x#16 | 10311.2x#16 | — | -35.8%#12 | -21982.6%#16 | -73.1%#16 | — | — | 210.6%#1 | — |
| ATRC | $3.0B#12 | 281.3x#10 | 5.8x#10 | 5.6x#12 | 14.9%#8 | 74.4%#4 | -1.8%#10 | -2.2%#9 | -2.3%#8 | 7#1 | 68.6%#4 | — |
| UFPT | $2.1B#13 | 29.8x#6 | 4.6x#8 | 3.5x#8 | 19.5%#5 | 15.8%#8 | 15.3%#4 | 14.8%#3 | 13.4%#2 | 7#1 | 34.1%#6 | — |
| INSP | $2.1B#14 | 16.1x#1 | 2.5x#5 | 2.3x#3 | 13.6%#10 | 171.8%#2 | 5.6%#8 | 17.6%#1 | 7.1%#3 | 7#1 | -9.1%#12 | — |
| NVCR | $1.9B#15 | — | 5.8x#9 | 3.0x#5 | 8.3%#13 | 19.4%#7 | -23.5%#13 | -40.3%#14 | -35.0%#10 | 3#10 | 31.8%#8 | — |
| LMAT | $1.8B#16 | 27.9x#5 | 4.3x#7 | 7.3x#13 | 13.5%#11 | 31.1%#6 | 27.2%#1 | 13.7%#4 | — | — | -12.6%#13 | 1.0%#2 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice